Skip to main content

Table 3 Endoscopic findings at baseline, n (%)

From: Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study

 

Children < 20 kg

Children ≥20 kg

 

Category

Esomeprazole

5 mg

(0.3-0.6 mg/kg)

(n = 26)

Esomeprazole 10 mg

(0.6-1.0 mg/kg)

(n = 23)

Esomeprazole 10 mg

(0.2-0.5 mg/kg)

(n = 31)

Esomeprazole 20 mg

(0.3-1.0 mg/kg)

(n = 29)

Total

(N = 109)

Other reflux esophagitis

14 (54)

11 (48)

15 (48)

16 (55)

56 (52)

Erosive esophagitis

12 (46)

12 (52)

16 (52)

13 (45)

53 (49)

   LA grade A

6 (23)

6 (26)

11 (36)

9 (31)

32 (29)

   LA grade B

6 (23)

5 (22)

5 (16)

3 (10)

19 (17)

   LA grade C

0

1 (4)

0

0

1 (1)

   LA grade D

0

0

0

1 (3)

1 (1)

Hiatal hernia

4 (15)

3 (13)

8 (26)

4 (14)

19 (17)

Other abnormality*

11 (42)

10 (44)

16 (52)

18 (62)

55 (50)

  1. *Abnormalities occurring in ≥4 patients were nodularity (n = 20 [18%]), erythema/hyperemia (n = 23 [21%]), edema (n = 11 [10%]), prominent esophageal folds (n = 11 [10%]), and friability (n = 4 [4%]).
  2. LA: Los Angeles.